SKLICE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sklice, and when can generic versions of Sklice launch?
Sklice is a drug marketed by Arbor Pharms Llc and is included in one NDA.
The generic ingredient in SKLICE is ivermectin. There are five drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sklice
A generic version of SKLICE was approved as ivermectin by EDENBRIDGE PHARMS on October 24th, 2014.
Summary for SKLICE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Clinical Trials: | 5 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SKLICE |
Drug Sales Revenues: | Drug sales revenues for SKLICE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SKLICE |
What excipients (inactive ingredients) are in SKLICE? | SKLICE excipients list |
DailyMed Link: | SKLICE at DailyMed |
Recent Clinical Trials for SKLICE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
City of Hope Medical Center | Phase 2 |
National Cancer Institute (NCI) | Phase 2 |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
Pharmacology for SKLICE
Drug Class | Antiparasitic Pediculicide |
Anatomical Therapeutic Chemical (ATC) Classes for SKLICE
Paragraph IV (Patent) Challenges for SKLICE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SKLICE | Lotion | ivermectin | 0.50% | 202736 | 1 | 2017-09-01 |
US Patents and Regulatory Information for SKLICE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SKLICE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SKLICE
See the table below for patents covering SKLICE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2155190 | FORMULATIONS TOPIQUES ET PROCÉDÉS D'ÉLIMINATION ET DE PROPHYLAXIE DE SOUCHES DE POUX SUSCEPTIBLES ET RÉSISTANTES AU TRAITEMENT AVEC DE MULTIPLES MODES D'ACTION (TOPICAL FORMULATIONS AND METHODS FOR ELIMINATION AND PROPHYLAXIS OF SUSCEPTIBLE AND TREATMENT RESISTANT STRAINS OF HEAD LICE WITH MULTIPLE MODES OF ACTION) | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2008067054 | ⤷ Try a Trial | |
European Patent Office | 2653160 | Formulations topiques d'ivermectine et procédés d'élimination et prophylaxie de souches des morpions (Topical ivermectin formulations and methods for elimination and prophylaxis of body lice) | ⤷ Try a Trial |
South Korea | 20110101138 | PRESERVATIVE SYSTEM FOR EMULSION-BASED THERAPEUTIC TOPICAL FORMULATIONS | ⤷ Try a Trial |
European Patent Office | 2091325 | Formulation shampooing-après-shampooing comprenant un avermectine pour l'élimination et la prophylaxie contre les souches de poux sensibles et résistantes aux traitements (Shampoo-conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment-resistant strains of lice) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SKLICE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1620113 | C01620113/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINUM; REGISTRATION NO/DATE: AUTORISATION SWISSMEDIC 65561 20.12.2016 |
1620113 | 2015/046 | Ireland | ⤷ Try a Trial | PRODUCT NAME: IVERMECTIN; NAT REGISTRATION NO/DATE: PA0590/028/001 20150424; FIRST REGISTRATION NO/DATE: MA117/01101 20150402 |
1620113 | C300756 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN; NAT. REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MA117/01101 20150402 |
1620113 | 300756 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN DE BEHANDELING VAN ROSACEA; NATIONAL REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MT MA117/01101 20150402 |
1620113 | 56/2015 | Austria | ⤷ Try a Trial | PRODUCT NAME: IVERMECTIN; NAT. REGISTRATION NO/DATE: 136170 20150602; FIRST REGISTRATION: MT MA 117/01101 20150402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |